Kommisjonens gjennomføringsbeslutning (EU) 2026/783 av 27. mars 2026 om endring av vedlegget til gjennomføringsbeslutning (EU) 2023/2447 om hastetiltak overfor utbrudd av høypatogen aviær influensa i visse medlemsstater
Hastetiltak mot utbrudd av høypatogen aviær influensa i Tsjekkia, Nederland, Polen, Tyskland og Storbritannia hva angår Nord-Irland
Kommisjonsbeslutning publisert i EU-tidende 31.3.2026
Bakgrunn
(fra kommisjonsbeslutningen)
(1) Highly pathogenic avian influenza (HPAI) is an infectious viral disease in birds and can have a severe impact on the profitability of poultry farming causing disturbance to trade within the Union and exports to third countries. HPAI viruses can infect migratory birds, which can then spread these viruses over long distances during their autumn and spring migrations. Therefore, the presence of HPAI viruses in wild birds poses a continuous threat for the direct and indirect introduction of these viruses into establishments where poultry or captive birds are kept. In the event of an outbreak of HPAI in establishments where poultry or captive birds are kept, there is a risk that the disease agent may spread to other such establishments.
(2) Regulation (EU) 2016/429 establishes the legislative framework for the prevention and control of diseases that are transmissible to animals or humans. HPAI falls within the definition of a listed disease in that Regulation, and it is subject to the disease prevention and control rules laid down therein. In addition, Commission Delegated Regulation (EU) 2020/687 (2) supplements Regulation (EU) 2016/429 as regards the rules for the prevention and control of certain listed diseases, including HPAI. In particular, Article 21 of that Delegated Regulation provides that in the event of an outbreak of a category A disease in an establishment, the competent authority is to immediately establish a restricted zone comprising a protection zone, a surveillance zone, and if necessary, further restricted zones around or adjacent to the protection and surveillance zones.
(3) Commission Implementing Decision (EU) 2023/2447 (3) was adopted on the basis of Regulation (EU) 2016/429, and it lays down emergency measures at Union level in relation to outbreaks of HPAI.
(4) In particular, Article 2, point (a), Article 3, point (a), and Article 4, point (a) of Implementing Decision (EU) 2023/2447 provide, respectively, that following outbreaks of HPAI, the protection, surveillance, and further restricted zones to be established in accordance with Delegated Regulation (EU) 2020/687 must comprise at least the areas listed as protection, surveillance, and further restricted zones in that Annex. Article 2, point (b), Article 3, point (b), and Article 4, point (b) of Implementing Decision (EU) 2023/2447 also provide that the measures to be applied in those protection, surveillance, and further restricted zones, in accordance with that Delegated Regulation, must be maintained until at least the dates set out in the Annex to that Implementing Decision.
(5) The Annex to Implementing Decision (EU) 2023/2447 was last amended by Commission Implementing Decision EU 2026/721 (4) following outbreaks of HPAI in Czechia, Denmark, Germany, France, Italy, Poland, and the United Kingdom in respect of Northern Ireland in establishments where poultry or captive birds were kept.
(6) Since the date of adoption of Implementing Decision (EU) 2026/721, Czechia, the Netherlands and Poland have notified the Commission of new outbreaks of HPAI in those Member States in establishments where poultry were kept. In particular, these notifications concerned two outbreaks in poultry in the Hradec Králové and Nymburk regions in Czechia, two outbreaks in the provinces of Drenthe and Noord Brabant in the Netherlands, and three outbreaks in the Łódzkie, Warmińsko-Mazurskie, and Wielkopolskie voivodeships in Poland.
(7) Following those seven new outbreaks, Czechia, the Netherlands and Poland have taken the disease control measures required in accordance with Delegated Regulation (EU) 2020/687, including the establishment of protection and surveillance zones around the outbreaks.
(8) The Commission has examined the disease control measures taken by Czechia, the Netherlands and Poland, and it is satisfied that the boundaries of the protection and surveillances zones established by the respective Member States for the outbreaks described are at a sufficient distance from the establishments where the outbreaks of HPAI have been confirmed.
(9) The United Kingdom in respect of Northern Ireland informed the Commission of the date of the cleaning and disinfection in the establishment affected by outbreak XI-HPAI(P)-2026-00001 located in the Derry City and Strabane district. Consequently, the duration of the protection and surveillance zones established for that outbreak by the United Kingdom in respect of Northern Ireland needs to be extended with one day, in accordance with Article 39 and Article 55 of Delegated Regulation (EU) 2020/687.
(10) In addition, the cleaning and disinfection in the establishments affected by outbreaks DE-HPAI(P)-2026-00034 located in the state of Niedersachsen in Germany, and PL-HPAI(P)-2026-00047 located in the Wielkopolskie voivodeship in Poland has been completed later than expected. Therefore, the duration of the protection and surveillance zones established for those outbreaks by Germany and Poland, respectively, needs to be extended, in accordance with Article 39 and Article 55 of Delegated Regulation (EU) 2020/687.
(11) In order to prevent any unnecessary disturbance to trade within the Union and to avoid any unjustified disruptions to trade being imposed by third countries, it is necessary to rapidly lay down at Union level, in collaboration with Czechia, the Netherlands and Poland the protection and surveillance zones established by those Member States in accordance with Delegated Regulation (EU) 2020/687.
(12) Therefore, the list of areas to be subject to protection and surveillance zones for Czechia, the Netherlands and Poland in the Annex to Implementing Decision (EU) 2023/2447 should be amended, to take account of the appropriate boundaries of the protection and surveillance zones as established by those Member States, following the new HPAI outbreaks therein, and the required duration of the measures to be applied in those zones needs to be set out, in accordance with Delegated Regulation (EU) 2020/687.
(13) In addition, the dates until which the measures are to be applied in the protection and surveillance zones established by Germany for outbreak DE-HPAI(P)-2026-00034, by Poland for outbreak PL-HPAI(P)-2026-00047, and by the United Kingdom in respect of Northern Ireland for outbreak XI-HPAI(P)-2026-00001, as listed in the Annex to Implementing Decision (EU) 2023/2447 should be amended to take account of the extended duration of the restrictions.
(14) The Annex to Implementing Decision (EU) 2023/2447 should, therefore, be amended accordingly.
(15) Given the urgency of the epidemiological situation in the Union as regards the spread of HPAI, it is important that the amendments to be made to the Annex to Implementing Decision (EU) 2023/2447 by this Decision take effect as soon as possible.
(16) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,